AUG 10, 2026 · JOURNAL ARTICLE
Ribociclib-based combination endocrine therapy in elderly and frail patients: key issues of efficacy, safety, and drug interactions requiring the attention of an oncologist
P a Herzen Journal of Oncology
A narrative review synthesizing Phase 3 RCT evidence, real-world studies, and FDA analyses to provide practical clinical recommendations on ribociclib use in elderly and frail patients, rather than reporting a new primary trial result.
Reported
ECOG performance status threshold…≥2